20140100156EXENDIN-4 DERIVATIVES AS DUAL GLP1/GLUCAGON AGONISTS - The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.04-10-2014